Structure Elucidation and Initial Characterization of a N-glucuronide Metabolite (M1) of Tuvusertib

Benedikt Lang, Hanno Schieferstein, Kai Thede, Matthias Bader, Tianjing Ren, Jatinder Kaur Mukker, Holger Scheible · 2026

Read Structure Elucidation and Initial Characterization of a N-glucuronide Metabolite (M1) of Tuvusertib by Benedikt Lang, Hanno Schieferstein, Kai Thede, Matthias Bader, Tianjing Ren, Jatinder Kaur Mukker, Holger Scheible (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13275781.txt.

Description

Benedikt Lang and co-authors pin down a breakdown product of a cancer drug in a 2026 study. The drug, tuvusertib, blocks the cell's DNA-damage response and is still in testing. Liver cell tests showed it gains a glucuronide tag, but early tools could not say where the tag sits.

The team built the tagged form by synthesis to get enough pure material. Nuclear magnetic resonance then read its exact structure, confirming the nitrogen site of tagging. Bench tests checked whether the product could spark drug interactions or safety issues. Knowing a metabolite's shape early helps dose design. It also flags pairing risks before large human trials begin.

Catalog record

CREATORBenedikt Lang, Hanno Schieferstein, Kai Thede, Matthias Bader, Tianjing Ren, Jatinder Kaur Mukker, Holger Scheible
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13275781

Browse the full library · About the Tower of Babel